XML 32 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY: (Details) (USD $)
3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 0 Months Ended 6 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Mar. 31, 2013
Sep. 30, 2013
Minimum
Sep. 30, 2012
Minimum
Sep. 30, 2013
Minimum
Sep. 30, 2012
Minimum
Sep. 30, 2013
Maximum
Sep. 30, 2012
Maximum
Sep. 30, 2013
Maximum
Sep. 30, 2012
Maximum
Aug. 29, 2011
2011 Common stock repurchase program
Sep. 30, 2013
2011 Common stock repurchase program
EARNINGS PER SHARE AND STOCKHOLDERS' EQUITY:                              
Range of exercise prices for options and warrants (in dollars per share)           $ 21.46 $ 17.76 $ 21.46 $ 15.31 $ 62.06 $ 62.06 $ 62.06 $ 62.06    
Stockholders' Equity                              
Maximum amount of common stock that may be repurchased                           $ 200,000,000  
Shares repurchased                             1,600,000
Repurchase of treasury stock     38,837,000 47,100,000                     38,800,000
Cumulative shares repurchased                             12,000,000
Cumulative amount paid for repurchase of treasury stock 923,771,000   923,771,000   882,959,000                   178,800,000
Remaining capacity under the stock repurchase program                             21,200,000
Basic earnings per share:                              
Net earnings 9,864,000 16,372,000 22,959,000 29,571,000                      
Net gain (loss) attributable to noncontrolling interest 25,000 (139,000) (60,000) (273,000)                      
Net earnings attributable to Acxiom 9,839,000 16,511,000 23,019,000 29,844,000                      
Basic weighted-average shares outstanding 73,778,000 75,009,000 73,728,000 75,741,000                      
Net earnings (in dollars per share) $ 0.13 $ 0.22 $ 0.31 $ 0.39                      
Net earnings attributable to Acxiom (in dollars per share) $ 0.13 $ 0.22 $ 0.31 $ 0.39                      
Diluted earnings per share:                              
Basic weighted-average shares outstanding 73,778,000 75,009,000 73,728,000 75,741,000                      
Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method (in shares) 2,258,000 2,016,000 2,036,000 1,800,000                      
Diluted weighted-average shares outstanding 76,036,000 77,025,000 75,764,000 77,541,000                      
Net earnings (in dollars per share) $ 0.13 $ 0.21 $ 0.30 $ 0.38                      
Net earnings (loss) attributable to Acxiom (in dollars per share) $ 0.13 $ 0.21 $ 0.30 $ 0.38                      
Stockholders' Equity                              
Outstanding options and warrants for the purchase of common stock (in shares) 8,500,000   8,500,000                        
Outstanding restricted stock units for purchase of common stock (in shares) 2,200,000   2,200,000                        
Number of shares outstanding under options, warrants and restricted stock units 2,224,000 4,762,000 3,390,000 7,093,000                      
Accumulated Other Comprehensive Income                              
Foreign currency translation 13,088,000   13,088,000   12,175,000                    
Unrealized loss on interest rate swap (334,000)   (334,000)   (752,000)                    
Accumulated Other Comprehensive Income $ 12,754,000   $ 12,754,000   $ 11,423,000